These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Toll-like receptor genes and their association with colon and rectal cancer development and prognosis. Slattery ML; Herrick JS; Bondurant KL; Wolff RK Int J Cancer; 2012 Jun; 130(12):2974-80. PubMed ID: 21792899 [TBL] [Abstract][Full Text] [Related]
9. PPARgamma and colon and rectal cancer: associations with specific tumor mutations, aspirin, ibuprofen and insulin-related genes (United States). Slattery ML; Curtin K; Wolff R; Ma KN; Sweeney C; Murtaugh M; Potter JD; Levin TR; Samowitz W Cancer Causes Control; 2006 Apr; 17(3):239-49. PubMed ID: 16489531 [TBL] [Abstract][Full Text] [Related]
10. Associations between genetic variation in RUNX1, RUNX2, RUNX3, MAPK1 and eIF4E and riskof colon and rectal cancer: additional support for a TGF-β-signaling pathway. Slattery ML; Lundgreen A; Herrick JS; Caan BJ; Potter JD; Wolff RK Carcinogenesis; 2011 Mar; 32(3):318-26. PubMed ID: 21088106 [TBL] [Abstract][Full Text] [Related]
11. Genetic variation in C-reactive protein in relation to colon and rectal cancer risk and survival. Slattery ML; Curtin K; Poole EM; Duggan DJ; Samowitz WS; Peters U; Caan BJ; Potter JD; Ulrich CM Int J Cancer; 2011 Jun; 128(11):2726-34. PubMed ID: 20949557 [TBL] [Abstract][Full Text] [Related]
12. MAPK genes interact with diet and lifestyle factors to alter risk of breast cancer: the Breast Cancer Health Disparities Study. Slattery ML; Lundgreen A; John EM; Torres-Mejia G; Hines L; Giuliano AR; Baumgartner KB; Stern MC; Wolff RK Nutr Cancer; 2015; 67(2):292-304. PubMed ID: 25629224 [TBL] [Abstract][Full Text] [Related]
13. Variation in the CYP19A1 gene and risk of colon and rectal cancer. Slattery ML; Lundgreen A; Herrick JS; Kadlubar S; Caan BJ; Potter JD; Wolff RK Cancer Causes Control; 2011 Jul; 22(7):955-63. PubMed ID: 21479914 [TBL] [Abstract][Full Text] [Related]
14. COX-1 (PTGS1) and COX-2 (PTGS2) polymorphisms, NSAID interactions, and risk of colon and rectal cancers in two independent populations. Makar KW; Poole EM; Resler AJ; Seufert B; Curtin K; Kleinstein SE; Duggan D; Kulmacz RJ; Hsu L; Whitton J; Carlson CS; Rimorin CF; Caan BJ; Baron JA; Potter JD; Slattery ML; Ulrich CM Cancer Causes Control; 2013 Dec; 24(12):2059-75. PubMed ID: 24022467 [TBL] [Abstract][Full Text] [Related]
16. Variants in the alpha-Methylacyl-CoA racemase gene and the association with advanced distal colorectal adenoma. Daugherty SE; Platz EA; Shugart YY; Fallin MD; Isaacs WB; Chatterjee N; Welch R; Huang WY; Hayes RB Cancer Epidemiol Biomarkers Prev; 2007 Aug; 16(8):1536-42. PubMed ID: 17684125 [TBL] [Abstract][Full Text] [Related]
17. Genetic variation in the transforming growth factor-β signaling pathway and survival after diagnosis with colon and rectal cancer. Slattery ML; Lundgreen A; Herrick JS; Wolff RK; Caan BJ Cancer; 2011 Sep; 117(18):4175-83. PubMed ID: 21365634 [TBL] [Abstract][Full Text] [Related]
18. IL6 genotypes and colon and rectal cancer. Slattery ML; Wolff RK; Herrick JS; Caan BJ; Potter JD Cancer Causes Control; 2007 Dec; 18(10):1095-105. PubMed ID: 17694420 [TBL] [Abstract][Full Text] [Related]
19. Genetic variation in RPS6KA1, RPS6KA2, RPS6KB1, RPS6KB2, and PDK1 and risk of colon or rectal cancer. Slattery ML; Lundgreen A; Herrick JS; Wolff RK Mutat Res; 2011 Jan; 706(1-2):13-20. PubMed ID: 21035469 [TBL] [Abstract][Full Text] [Related]
20. Energy balance, insulin-related genes and risk of colon and rectal cancer. Slattery ML; Murtaugh M; Caan B; Ma KN; Neuhausen S; Samowitz W Int J Cancer; 2005 May; 115(1):148-54. PubMed ID: 15688407 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]